The management of cryptogenic fibrosing alveolitis in three regions of the United KingdomCitation formats

  • Authors:
  • I. D A Johnston
  • S. A. Gomm
  • S. Kalra
  • A. A. Woodcock
  • C. C. Evans
  • And 1 others
  • External authors:
  • C. R K Hind

Standard

The management of cryptogenic fibrosing alveolitis in three regions of the United Kingdom. / Johnston, I. D A; Gomm, S. A.; Kalra, S.; Woodcock, A. A.; Evans, C. C.; Hind, C. R K.

In: European Respiratory Journal, Vol. 6, No. 6, 1993, p. 891-893.

Research output: Contribution to journalArticle

Harvard

Johnston, IDA, Gomm, SA, Kalra, S, Woodcock, AA, Evans, CC & Hind, CRK 1993, 'The management of cryptogenic fibrosing alveolitis in three regions of the United Kingdom' European Respiratory Journal, vol. 6, no. 6, pp. 891-893.

APA

Johnston, I. D. A., Gomm, S. A., Kalra, S., Woodcock, A. A., Evans, C. C., & Hind, C. R. K. (1993). The management of cryptogenic fibrosing alveolitis in three regions of the United Kingdom. European Respiratory Journal, 6(6), 891-893.

Vancouver

Johnston IDA, Gomm SA, Kalra S, Woodcock AA, Evans CC, Hind CRK. The management of cryptogenic fibrosing alveolitis in three regions of the United Kingdom. European Respiratory Journal. 1993;6(6):891-893.

Author

Johnston, I. D A ; Gomm, S. A. ; Kalra, S. ; Woodcock, A. A. ; Evans, C. C. ; Hind, C. R K. / The management of cryptogenic fibrosing alveolitis in three regions of the United Kingdom. In: European Respiratory Journal. 1993 ; Vol. 6, No. 6. pp. 891-893.

Bibtex

@article{05a3499bde4346baa90c534b25edceb5,
title = "The management of cryptogenic fibrosing alveolitis in three regions of the United Kingdom",
abstract = "The case notes of 200 patients with cryptogenic fibrosing alveolitis, from three regions in the United Kingdom, were reviewed, in order to determine how physicians manage this uncommon condition. In the majority of cases (119), the diagnosis was based solely on clinical grounds, with no attempt at histological confirmation of the diagnosis. Transbronchial biopsy was attempted in 66 patients, but was unhelpful in confirming a diagnosis of pulmonary fibrosis in 30{\%} of these patients. Thirty five patients underwent bronchoalveolar lavage, and 15 had an open lung biopsy. Of the 132 patients treated, 110 received prednisolone alone, and the rest a combination of other immunosuppressive agents. The doses and duration of therapy varied considerably. These results suggest that, in the late 1980s, there were wide variations of practice in the management of cryptogenic fibrosing alveolitis in the United Kingdom. This is likely to reflect a paucity of information on the optimum management of this uncommon condition.",
keywords = "bronchoalveolar lavage, cryptogenic fibrosing alveolitis, transbronchial biopsy",
author = "Johnston, {I. D A} and Gomm, {S. A.} and S. Kalra and Woodcock, {A. A.} and Evans, {C. C.} and Hind, {C. R K}",
year = "1993",
language = "English",
volume = "6",
pages = "891--893",
journal = "The European respiratory journal",
issn = "0903-1936",
publisher = "European Respiratory Society",
number = "6",

}

RIS

TY - JOUR

T1 - The management of cryptogenic fibrosing alveolitis in three regions of the United Kingdom

AU - Johnston, I. D A

AU - Gomm, S. A.

AU - Kalra, S.

AU - Woodcock, A. A.

AU - Evans, C. C.

AU - Hind, C. R K

PY - 1993

Y1 - 1993

N2 - The case notes of 200 patients with cryptogenic fibrosing alveolitis, from three regions in the United Kingdom, were reviewed, in order to determine how physicians manage this uncommon condition. In the majority of cases (119), the diagnosis was based solely on clinical grounds, with no attempt at histological confirmation of the diagnosis. Transbronchial biopsy was attempted in 66 patients, but was unhelpful in confirming a diagnosis of pulmonary fibrosis in 30% of these patients. Thirty five patients underwent bronchoalveolar lavage, and 15 had an open lung biopsy. Of the 132 patients treated, 110 received prednisolone alone, and the rest a combination of other immunosuppressive agents. The doses and duration of therapy varied considerably. These results suggest that, in the late 1980s, there were wide variations of practice in the management of cryptogenic fibrosing alveolitis in the United Kingdom. This is likely to reflect a paucity of information on the optimum management of this uncommon condition.

AB - The case notes of 200 patients with cryptogenic fibrosing alveolitis, from three regions in the United Kingdom, were reviewed, in order to determine how physicians manage this uncommon condition. In the majority of cases (119), the diagnosis was based solely on clinical grounds, with no attempt at histological confirmation of the diagnosis. Transbronchial biopsy was attempted in 66 patients, but was unhelpful in confirming a diagnosis of pulmonary fibrosis in 30% of these patients. Thirty five patients underwent bronchoalveolar lavage, and 15 had an open lung biopsy. Of the 132 patients treated, 110 received prednisolone alone, and the rest a combination of other immunosuppressive agents. The doses and duration of therapy varied considerably. These results suggest that, in the late 1980s, there were wide variations of practice in the management of cryptogenic fibrosing alveolitis in the United Kingdom. This is likely to reflect a paucity of information on the optimum management of this uncommon condition.

KW - bronchoalveolar lavage

KW - cryptogenic fibrosing alveolitis

KW - transbronchial biopsy

M3 - Article

VL - 6

SP - 891

EP - 893

JO - The European respiratory journal

JF - The European respiratory journal

SN - 0903-1936

IS - 6

ER -